People · Operator
Named in public records as an officer, director or promoter · active 2024–2024 · Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| ExploraMed NC7, Inc. | — | Other Health Care | Series C | $181.5M | $752.1M | 2024 |
Sarah O'Leary at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Sarah O'Leary on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ryan Drant | 1 | 24 |
| Robert Anderson | 1 | 24 |
| Joshua Makower | 1 | 10 |
| Michael Carusi | 1 | 7 |
| ROBERT CROCE | 1 | 7 |
| Robert W. Croce | 1 | 7 |
| Robert K. Anderson | 1 | 6 |
| Scott Becker | 1 | 5 |
| Michael Chuisano | 1 | 5 |
| Joshua W. Makower | 1 | 4 |
| Naomi Kelman | 1 | 3 |
| Avinash Amin | 1 | 2 |
| Nina W Richardson | 1 | 2 |
| Andrew W Chmyz | 1 | 1 |
| Ivy W Ross | 1 | 1 |
| Stacy W Feld | 1 | 1 |
| Laura Chambers | 1 | 1 |
| Naomi G. Kelman | 1 | 1 |
| Addison Wright | 1 | 1 |
| Michael K. Carusi | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.